drugset / Trial / NCT00160901
Complementary Therapies for the Reduction of Side Effects During Chemotherapy for Breast Cancer
Phase 4
Completed
150 enrolled
Heidelberg University
Cefak KG, Kempten · collabHector-Stiftung · collabSchwabe-Wenex International Ltd · collabUrsapharm, Saarbrücken · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine wether a complementary therapy consisting of a combined medication of selenium, milk thistle, goldenrod and bromelain and a consultation concerning nutrition and physical activity can reduce side effects of a chemotherapy in breast cancer patients.
Timeline
- Start
- 2003-08
- Primary completion
- —
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Milk Thistle | Traditional medicine (herbal / TCM) | 280 mg | Oral |
| Subject | Selenium | Other / unclassified | 100 ug | Oral |
| Subject | bromelaine | Protein / enzyme biologic | 3000 unknown | Oral |
| Subject | goldenrod | Unknown | 1680 g | Oral |